2456 Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices 

1A record of the Commissioners’ votes is 

available from the Office of the Secretary and at the 

Commission’s website. 

2The Commission has found the response to its 

notice of institution filed by the United Steel, Paper 

and Forestry, Rubber, Manufacturing, Energy, 

Allied Industrial and Service Workers International 

Union (‘‘domestic interested party’’), which 

represents workers at five domestic producers of 

PVLT tires: Cooper Tire & Rubber Company, the 

Goodyear Tire & Rubber Company, Michelin North 

America Inc., Sumitomo Rubber USA, LLC, and the 

Yokohama Rubber Co., Ltd., to be adequate. 

Comments from other interested parties will not be 

accepted (see 19 CFR 207.62(d)(2)). 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 701–TA–522 and 731– 

TA–1258 (Review)] 

Passenger Vehicle and Light Truck 

Tires From China; Scheduling of 

Expedited Five-Year Reviews 

AGENCY: United States International 

Trade Commission. 

ACTION: Notice. 

SUMMARY: The Commission hereby gives 

notice of the scheduling of expedited 

reviews pursuant to the Tariff Act of 

1930 (‘‘the Act’’) to determine whether 

revocation of the countervailing and 

antidumping duty orders on passenger 

vehicle and light truck tires from China 

would be likely to lead to continuation 

or recurrence of material injury within 

a reasonably foreseeable time. 

DATES: October 5, 2020. 

FOR FURTHER INFORMATION CONTACT: 

Alejandro Orozco (202–205–3177), 

Office of Investigations, U.S. 

International Trade Commission, 500 E 

Street SW, Washington, DC 20436. 

Hearing-impaired persons can obtain 

information on this matter by contacting 

the Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server (https://

www.usitc.gov). The public record for 

these reviews may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. 

SUPPLEMENTARY INFORMATION: 

Background.—On October 5, 2020, the 

Commission determined that the 

domestic interested party group 

response to its notice of institution (85 

FR 39581, July 1, 2020) of the subject 

five-year reviews was adequate and that 

the respondent interested party group 

response was inadequate. The 

Commission did not find any other 

circumstances that would warrant 

conducting full reviews.1 Accordingly, 

the Commission determined that it 

would conduct expedited reviews 

pursuant to section 751(c)(3) of the 

Tariff Act of 1930 (19 U.S.C. 1675(c)(3)). 

For further information concerning 

the conduct of these reviews and rules 

of general application, consult the 

Commission’s Rules of Practice and 

Procedure, part 201, subparts A and B 

(19 CFR part 201), and part 207, 

subparts A, D, E, and F (19 CFR part 

207). 

Please note the Secretary’s Office will 

accept only electronic filings at this 

time. Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https://

edis.usitc.gov). No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. 

Staff report.—A staff report 

containing information concerning the 

subject matter of the reviews will be 

placed in the nonpublic record on 

January 8, 2021, and made available to 

persons on the Administrative 

Protective Order service list for these 

reviews. A public version will be issued 

thereafter, pursuant to section 

207.62(d)(4) of the Commission’s rules. 

Written submissions.—As provided in 

section 207.62(d) of the Commission’s 

rules, interested parties that are parties 

to the reviews and that have provided 

individually adequate responses to the 

notice of institution,2 and any party 

other than an interested party to the 

reviews may file written comments with 

the Secretary on what determination the 

Commission should reach in the 

reviews. Comments are due on or before 

January 14, 2021 and may not contain 

new factual information. Any person 

that is neither a party to the five-year 

reviews nor an interested party may 

submit a brief written statement (which 

shall not contain any new factual 

information) pertinent to the reviews by 

January 14, 2021. However, should the 

Department of Commerce (‘‘Commerce’’) 

extend the time limit for its completion 

of the final results of its reviews, the 

deadline for comments (which may not 

contain new factual information) on 

Commerce’s final results is three 

business days after the issuance of 

Commerce’s results. If comments 

contain business proprietary 

information (BPI), they must conform 

with the requirements of sections 201.6, 

207.3, and 207.7 of the Commission’s 

rules. The Commission’s Handbook on 

Filing Procedures, available on the 

Commission’s website at https://

www.usitc.gov/documents/handbook_

on_filing_procedures.pdf, elaborates 

upon the Commission’s procedures with 

respect to filings. 

In accordance with sections 201.16(c) 

and 207.3 of the rules, each document 

filed by a party to the reviews must be 

served on all other parties to the review 

(as identified by either the public or BPI 

service list), and a certificate of service 

must be timely filed. The Secretary will 

not accept a document for filing without 

a certificate of service. 

Determination.—The Commission has 

determined these reviews are 

extraordinarily complicated and 

therefore has determined to exercise its 

authority to extend the review period by 

up to 90 days pursuant to 19 U.S.C. 

1675(c)(5)(B). 

Authority: These reviews are being 

conducted under authority of title VII of the 

Tariff Act of 1930; this notice is published 

pursuant to section 207.62 of the 

Commission’s rules. 

By order of the Commission. 

Issued: January 7, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–00435 Filed 1–11–21; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–763] 

Importer of Controlled Substances 

Application: Medi-Physics, Inc. dba GE 

Healthcare 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Medi-Physics, Inc. dba GE 

Healthcare has applied to be registered 

as an importer of basic class(es) of 

controlled substance(s). Refer to 

Supplemental Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before February 11, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before February 11, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 7 / Tuesday, January 12, 2021 / Notices 2457 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on December 15, 2020, 

Medi-Physics, Inc. dba GE Healthcare, 

3350 North Ridge Avenue, Arlington 

Heights, Illinois 60004–1412, applied to 

be registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Cocaine ........................ 9041 II 

The company plans to import small 

quantities of Ioflupane, in the form of 

three separate analogues of Cocaine, to 

validate production and quality control 

systems, for a reference standard, and 

for producing material for a future 

investigational new drug submission. 

Supplies of this particular controlled 

substance are not available in the form 

needed within the current domestic 

supply of the United States. No other 

activity for this drug code is authorized 

for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–00353 Filed 1–11–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–756] 

Bulk Manufacturer of Controlled 

Substances Application: Cedarburg 

Pharmaceuticals 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Cedarburg Pharmaceuticals 

has applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplemental Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 15, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 15, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on October 16, 2020, 

Cedarburg Pharmaceuticals 870 Badger 

Circle, Grafton, Wisconsin 53024, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Tetrahydrocannabinols 7370 I 

3, 4- 

Methylenedioxymethamphetamine.

7405 I 

Dimethyltryptamine ....... 7435 I 

Psilocybin ..................... 7437 I 

Methylphenidate ........... 1724 II 

Nabilone ....................... 7379 II 

4-Anilino-N-phenethyl-4- 

piperidine (ANPP).

8333 II 

Fentanyl ........................ 9801 II 

The company plans to manufacture 

bulk active pharmaceutical ingredients 

(API) for distribution to its customers. In 

reference to the drug code 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture as synthetic. 

No other activity for this drug code is 

authorized for this registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–00351 Filed 1–11–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–765] 

Bulk Manufacturer of Controlled 

Substances Application: Organix, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Organix, Inc. has applied to 

be registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 15, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 15, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on September 22, 2020, 

Organix, Inc., 240 Salem Street, 

Woburn, Massachusetts 01801, applied 

to be registered as an bulk manufacturer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug code Schedule 

Gamma Hydroxybutyric Acid ........................................................................................................................................... 2010 I 

Lysergic acid diethylamide .............................................................................................................................................. 7315 I 

Marihuana ........................................................................................................................................................................ 7360 I 

Tetrahydrocannabinols .................................................................................................................................................... 7370 I 

5-Methoxy-N-N-dimethyltryptamine ................................................................................................................................. 7431 I 

Bufotenine ........................................................................................................................................................................ 7433 I 

Dimethyltryptamine .......................................................................................................................................................... 7435 I 

Psilocybin ......................................................................................................................................................................... 7437 I 

Psilocyn ........................................................................................................................................................................... 7438 I 

Heroin .............................................................................................................................................................................. 9200 I 


khammond on DSKJM1Z7X2PROD with NOTICES